Design and synthesis of a sulphur containing Schiff base drug: DNA binding studies and theoretical calculations

J Biomol Struct Dyn. 2021 Jan;39(1):263-271. doi: 10.1080/07391102.2019.1708799. Epub 2020 Jan 8.

Abstract

The Schiff base compound MTA ((E)-5-methyl-N'-((5-methylthiophen-2-yl)methylene)-1H-pyrazole-3-carbohydrazide) derived from 2-thiophenecarboxaldehyde and 5-methylpyrazole-3-carbohydrazide has been designed to develop new sulphur containing DNA targeted molecule. The MTA has been characterized by elemental analyses, 1H-NMR, single crystal X-ray diffraction studies as well as by geometry optimization of using DFT/B3LYP. The interaction of MTA with Calf thymus DNA (CT-DNA) was studied by spectroscopic and calorimetric techniques. The synthesized compound was found to bind with CT-DNA through groove binding mode, and the binding constant was estimated to be (4.15 ± 0.08) × 104 M-1. The negative ΔG0 and positive ΔS0 values obtained from the calorimetric technique confirmed the spontaneity of the binding of MTA with DNA.Communicated by Ramaswamy H. Sarma.

Keywords: CT DNA; Photophysical studies; Single crystal XRD; Sulphur containing Schiff base; Thermodynamic study.

MeSH terms

  • Crystallography, X-Ray
  • DNA
  • Pharmaceutical Preparations*
  • Schiff Bases*
  • Sulfur

Substances

  • Pharmaceutical Preparations
  • Schiff Bases
  • Sulfur
  • DNA